A recent study suggests that individuals who come off new slimming jabs like Wegovy and Mounjaro may regain reduced body mass much more quickly than those who halt traditional diet and exercise plans.
Research printed in a leading medical journal shows that while obese individuals frequently drop substantial amounts of their total mass while on the medication, the weight comes back at an estimated rate of 0.8 kg per month upon discontinuation.
"People using these treatments should be informed of the risk of fast weight regain when the therapy ends," stated expert Dr. Susan Jebb.
This pace of recovery implies a return to starting weight within about 18 months.
Weighing Treatments
The study, which looked at 37 of studies involving thousands of patients, contrasted the outcomes of these new drugs with older methods.
Researchers emphasize that people who shed pounds through dieting usually experience a slower creep back—perhaps 0.1 kg a month—once they finish.
Explaining the Fast Rebound
Doctors suggest the mechanism of the injections is key to understanding the accelerated weight return.
These medications mimic a body's own chemical called glucagon-like peptide-1, which moderates hunger.
"Sustained high doses of the hormone concentrations far above than normal could lead to the body to produce less of its own natural hormone, and may also reduce sensitivity to its effects," explained Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this medication leads to appetite is unsuppressed, making overeating far more likely."
A Chronic Issue?
Medical guidelines suggest the jabs for individuals with weight-linked health risks, alongside prescribed diet and exercise modifications.
Professionals argue that, due to the high risk of weight regain, the therapy should be considered life-long.
This perspective is reinforced by pharmaceutical companies, who state that the results "highlight the chronic character of obesity," comparing it to managing diseases like high blood pressure.
User Testimonies
People who have come off the medication describe a powerful resurgence of appetite.
"It was like a switch activating and you become starving," said an individual.
The struggle is compounded if patients have not developed lasting dietary or behavioural changes during therapy.
Widespread Interest
Survey data indicate that millions of people in the UK have used these injections in the last 12 months, with demand remaining high.
- Adoption is greater among women compared to males.
- The 40s and 50s demographic shows the greatest usage rates.
- Many access the medications through private healthcare rather than public health services.
In conclusion, experts caution that while these medications are effective tools for shedding pounds, they are not a permanent solution and long-term success hinges on integrated lifestyle changes.
